MarketPeel
Pricing
…
JL

John M. Leonard

IQV
DIRECTOR · IQVIA HOLDINGS INC. · CIK 0001563584
FILING MIX · LIFETIME38%/62%
BUYS
58
SELLS
94
TOTAL VALUE
$66.64M
COMPANIES
2
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
1,164,010
AVG SELL PX
$66.42
TRADE KIND
SHOWING 152 / 152
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
56 backtested trades · 8 horizons · 9 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by John M. Leonard, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d56+35.71%+4.70%+1.27%+3.43%+5.77%3.08
14d56+19.64%+5.19%+1.32%+3.86%+1.96%2.26
30d56+73.21%-1.71%+0.30%-2.00%-7.02%-0.69
60d56+44.64%+13.85%+3.88%+9.97%+5.91%2.24
90d56+48.21%+13.59%+6.26%+7.33%-1.09%1.24
180d56+35.71%+60.36%+9.31%+51.05%+67.09%5.04
1y56(4 pending)+44.23%+73.22%+12.66%+60.56%+21.37%2.38
2y56(5 pending)+80.39%-24.53%+10.84%-35.37%-45.50%-3.75
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IQV · 16,946 shares · as of Apr 23, 2026
04,2378,47312,71016,946202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 58 buys / 94 sellsCOVERAGE · 27 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
2,785$13.00$36.2K1,147,064Aug 21, 2026Aug 24, 2026 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
19,890$12.60$250.6K1,149,849Aug 20, 2026Aug 24, 2026 ↗View →
IQV
IQVIA HOLDINGS INC.
PURCHASEGRANT
Stock grant
1,571——16,946Apr 23, 2026Apr 27, 2026 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
225,400——225,400Mar 1, 2026Mar 3, 2026 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
156,400——1,169,739Mar 1, 2026Mar 3, 2026 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
34,146$9.21$314.5K1,013,339Jan 5, 2026Jan 7, 2026 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
8,557$6.83$58.4K1,047,485Dec 12, 2025Dec 12, 2025 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
8,557——0Dec 12, 2025Dec 12, 2025 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
49,959——8,557Dec 11, 2025Dec 12, 2025 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
49,959$6.83$341.2K1,127,074Dec 11, 2025Dec 12, 2025 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,355$9.59$51.4K1,038,928Dec 11, 2025Dec 12, 2025 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
32,832$9.47$310.9K1,044,283Dec 11, 2025Dec 12, 2025 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
49,959$9.49$474.1K1,077,115Dec 11, 2025Dec 12, 2025 ↗View →
IQV
IQVIA HOLDINGS INC.
PURCHASEGRANT
Stock grant
1,592——15,375Apr 24, 2025Apr 25, 2025 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
136,000——1,077,115Mar 1, 2025Mar 4, 2025 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
196,000——196,000Mar 1, 2025Mar 4, 2025 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
26,807$12.18$326.5K941,115Jan 3, 2025Jan 7, 2025 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
7,850——967,922Jan 1, 2025Jan 3, 2025 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
7,850——0Jan 1, 2025Jan 3, 2025 ↗View →
IQV
IQVIA HOLDINGS INC.
PURCHASEGRANT
Stock grant
1,047——13,783May 7, 2024May 9, 2024 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
163,929——163,929Mar 1, 2024Mar 5, 2024 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
113,586——960,072Mar 1, 2024Mar 5, 2024 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
19,223$29.46$566.3K846,486Jan 3, 2024Jan 5, 2024 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
7,848——865,709Jan 1, 2024Jan 3, 2024 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
7,848——7,850Jan 1, 2024Jan 3, 2024 ↗View →
IQV
IQVIA HOLDINGS INC.
PURCHASEGRANT
Stock grant
1,063——12,736May 10, 2023May 12, 2023 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
91,036——857,861Mar 1, 2023Mar 3, 2023 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
128,631——128,631Mar 1, 2023Mar 3, 2023 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
6,673$37.21$248.3K766,825Jan 4, 2023Jan 6, 2023 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
7,848——15,698Jan 1, 2023Jan 4, 2023 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
7,848——773,498Jan 1, 2023Jan 4, 2023 ↗View →
IQV
IQVIA HOLDINGS INC.
PURCHASEGRANT
Stock grant
995——11,673May 11, 2022May 13, 2022 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,990——765,650Mar 1, 2022Mar 4, 2022 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
59,941——59,941Mar 1, 2022Mar 4, 2022 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
7,848——727,153Jan 1, 2022Mar 4, 2022 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
7,848——23,546Jan 1, 2022Mar 4, 2022 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
2,493$112.26$279.9K724,660Jan 1, 2022Mar 4, 2022 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
28,750$23.46$674.5K748,055Sep 1, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
15,985——11,515Sep 1, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
28,750——0Sep 1, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
15,985$18.30$292.5K764,040Sep 1, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
44,735$170.00$7.60M719,305Sep 1, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
37,833$155.00$5.86M719,305Aug 31, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
37,833$14.58$551.6K757,138Aug 31, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
37,833——90,000Aug 31, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
7,428$154.98$1.15M746,292Aug 30, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
2,598$159.18$413.5K720,246Aug 30, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
216$160.69$34.7K719,305Aug 30, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
11,637$13.40$155.9K730,942Aug 30, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
4,758$156.96$746.8K725,967Aug 30, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
2,055$152.81$314.0K756,054Aug 30, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
11,637——212,501Aug 30, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
2,334$153.66$358.6K753,720Aug 30, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
27,167——127,833Aug 30, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
3,123$157.75$492.7K722,844Aug 30, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
15,567$155.70$2.42M730,725Aug 30, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
725$159.98$116.0K719,521Aug 30, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
27,167$14.58$396.1K758,109Aug 30, 2021Sep 1, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
27,139——224,138Aug 23, 2021Aug 25, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
100$153.52$15.4K719,305Aug 23, 2021Aug 25, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
8,165$153.08$1.25M719,405Aug 23, 2021Aug 25, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
18,874$151.54$2.86M727,570Aug 23, 2021Aug 25, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
27,139$13.40$363.7K746,444Aug 23, 2021Aug 25, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
9,726$150.46$1.46M732,261Aug 19, 2021Aug 20, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
22,682——251,277Aug 19, 2021Aug 20, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
22,682$13.40$303.9K741,987Aug 19, 2021Aug 20, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
5,963$152.30$908.2K719,305Aug 19, 2021Aug 20, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
6,993$151.56$1.06M725,268Aug 19, 2021Aug 20, 2021 ↗View →
IQV
IQVIA HOLDINGS INC.
PURCHASEGRANT
Stock grant
934——10,678Apr 15, 2021Apr 19, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
15,937——15,937Apr 13, 2021Apr 15, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
15,937$13.88$221.2K719,305Apr 13, 2021Apr 15, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
10,000——10,000Apr 13, 2021Apr 15, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
10,000$6.83$68.3K703,368Apr 13, 2021Apr 15, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
26,041——273,959Apr 1, 2021Apr 2, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
26,041$13.40$348.9K707,263Apr 1, 2021Apr 2, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
45,000——155,000Apr 1, 2021Apr 2, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
45,000$14.58$656.1K705,536Apr 1, 2021Apr 2, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
13,895$83.00$1.15M693,368Apr 1, 2021Apr 2, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
24,314$84.00$2.04M681,222Apr 1, 2021Apr 2, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
188,363——188,363Mar 3, 2021Mar 5, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
31,394——31,394Mar 3, 2021Mar 5, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
56,718$6.83$387.4K688,579Feb 9, 2021Feb 9, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
28,043$75.00$2.10M660,536Feb 9, 2021Feb 9, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
56,718——68,516Feb 9, 2021Feb 9, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
8,043$67.18$540.3K646,760Feb 5, 2021Feb 9, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
40,000$13.40$536.0K654,803Feb 5, 2021Feb 9, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
14,018$67.86$951.3K632,742Feb 5, 2021Feb 9, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
881$68.78$60.6K631,861Feb 5, 2021Feb 9, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
40,000——285,453Feb 5, 2021Feb 9, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
67,060——17,940Feb 3, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
36,858$73.00$2.69M614,803Feb 3, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
67,060$13.88$930.8K651,661Feb 3, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
50,000——110,000Feb 3, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
30,998$72.00$2.23M584,601Feb 3, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
50,000$22.78$1.14M615,599Feb 3, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
10,000——85,000Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
16,750$63.32$1.06M558,738Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
26,058$64.13$1.67M532,680Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
5,475$65.04$356.1K565,599Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
6,448$63.29$408.1K551,506Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
60,000$22.78$1.37M598,814Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
3,260$65.03$212.0K538,814Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
60,000——160,000Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
30,000$18.30$549.0K557,954Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
16,640$64.10$1.07M571,074Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
3,497$64.16$224.4K528,647Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
9,432$64.09$604.5K542,074Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
8,827$65.00$573.8K523,853Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
693$65.02$45.1K527,954Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
100,000——125,234Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
11,100$63.30$702.6K587,714Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
10,000$13.88$138.8K533,853Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
30,000——27,500Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
100,000$6.83$683.0K575,488Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
1,709$63.24$108.1K532,144Feb 1, 2021Feb 3, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
6,239$55.86$348.5K475,488Jan 5, 2021Jan 5, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,375——14,375Dec 31, 2020Jan 5, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
28,750——28,750Dec 31, 2020Jan 5, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
14,375——0Dec 31, 2020Jan 5, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
14,375——481,727Dec 31, 2020Jan 5, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
15,000$38.00$570.0K467,352Nov 27, 2020Nov 27, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
20,000$39.00$780.0K467,352Nov 27, 2020Nov 27, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
20,000——200,000Nov 27, 2020Nov 27, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
15,000——57,500Nov 27, 2020Nov 27, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
20,000$14.58$291.6K487,352Nov 27, 2020Nov 27, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
15,000$18.30$274.5K482,352Nov 27, 2020Nov 27, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
50,000$6.83$341.5K517,352Nov 25, 2020Nov 25, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
50,000$36.00$1.80M467,352Nov 25, 2020Nov 25, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
50,000——225,234Nov 25, 2020Nov 25, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
20,000$34.00$680.0K467,352Nov 16, 2020Nov 18, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
20,000$14.58$291.6K487,352Nov 16, 2020Nov 18, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
20,000——220,000Nov 16, 2020Nov 18, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
50,000$26.00$1.30M467,352Nov 4, 2020Nov 6, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
50,000——275,234Nov 4, 2020Nov 6, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
50,000$6.83$341.5K517,352Nov 4, 2020Nov 6, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
5,000$6.83$34.1K472,352Oct 7, 2020Oct 9, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
5,000——325,234Oct 7, 2020Oct 9, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
5,000$21.83$109.2K467,352Oct 7, 2020Oct 9, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
5,000$21.83$109.2K467,352Sep 1, 2020Sep 3, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
5,000——330,234Sep 1, 2020Sep 3, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
5,000$6.83$34.1K472,352Sep 1, 2020Sep 3, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
5,000$6.83$34.1K472,352Aug 6, 2020Aug 7, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
5,000$21.83$109.2K467,352Aug 6, 2020Aug 7, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
5,000——335,234Aug 6, 2020Aug 7, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
5,000——340,234Jul 1, 2020Jul 2, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
5,000$21.83$109.2K467,352Jul 1, 2020Jul 2, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
5,000$6.83$34.1K472,352Jul 1, 2020Jul 2, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
5,000——345,234Jun 3, 2020Jun 5, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
President and CEO
5,000$21.83$109.2K467,352Jun 3, 2020Jun 5, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
President and CEO
5,000$6.83$34.1K472,352Jun 3, 2020Jun 5, 2020 ↗View →
IQV
IQVIA HOLDINGS INC.
PURCHASEGRANT
Stock grant
1,492——9,744May 6, 2020May 8, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
340,000——340,000Mar 2, 2020Mar 4, 2020 ↗View →
Other insiders · IQV
Loading peer insiders…
About this filer
CIK 0001563584
ROLE
Director
PRIMARY
IQV
COMPANIES
2
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001563584DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback